Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-26 @ 11:17 PM
Study NCT ID:
NCT02830932
Status:
COMPLETED
Last Update Posted:
2018-08-16
First Post:
2016-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)
Sponsor:
Vaxart
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-23
First Submit QC Date:
None
Study First Post Date:
2016-07-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-14
Last Update Post Date:
2018-08-16
Last Update Post Date Type:
ACTUAL